We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DR. REDDY'S BRINGS NEW CHALLENGE TO PFIZER'S NORVASC
DR. REDDY'S BRINGS NEW CHALLENGE TO PFIZER'S NORVASC
February 24, 2004
Generic firm Dr. Reddy’s yesterday said it had filed an application to market a bioequivalent version of Pfizer’s top-selling hypertension drug Norvasc (amlodipine besylate) — just two weeks after it reported the FDA had stayed final approval for Dr. Reddy’s slightly different version of the product.